Imaging in chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 2, 2007, Pages 143-161

  Shaker, Saher B ^a,c   Dirksen, Asger ^a   Bach, Karen S ^a   Mortensen, Jann ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c NONE   (Denmark)

Author keywords

Chest x ray; Chronic bronchitis; Computed tomography; Emphysema; Quantitative CT

Indexed keywords

ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FIBROSIS; HUMAN; IMAGING; LUNG EMPHYSEMA; LUNG VENTILATION PERFUSION RATIO; MUCOCILIARY CLEARANCE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX RADIOGRAPHY; RADIOGRAPHY; REVIEW; SCINTISCANNING;

BRONCHITIS, CHRONIC; HUMANS; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547406843     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701341277     Document Type: Article

References (104)

1. Snider GL, Kleinerman JL, Thurlbeck WM. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis 1985; 132:182-185.
2. Thurlbeck WM. Pathology of the Lung, 1. ed. Thieme Medical Publishers, Inc., New York; 1988.
3. Remy-Jardin M, Remy J, Gosselin B, Becette V, Edme JL. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993; 186:643-651.
4. Saetta M, Kim WD, Izquierdo JL, Ghezzo H, Cosio MG. Extent of centrilobular and panacinar emphysema in smokers' lungs: Pathological and mechanical implications. Eur Respir J 1994; 7:664-671.
5. Reid L, Millard FJC. Correlation between radiological diagnosis and structural lung changes in emphysema. Clin Radiol 1964; 15:307-311.
6. Thurlbeck WM, Simon G. Radiographic appearance of the chest in emphysema. AJR Am J Roentgenol 1978; 130:429-440.
7. Sutinen S, Christoforidis AJ, Klugh GA, Pratt PC. Roentgenologic criteria for the recognition of nonsymptomatic pulmonary emphysema. Am Rev Respir Dis 1965; 91:69-76.
8. Nicklaus TM, Stowell DW, Christiansen WR, Renzetti AD, Jr. The accuracy of the Roentgenologic diagnosis of chronic pulmonary emphysema. Am Rev Respir Dis 1966; 93:889-899.
9. Reich SB, Weinshelbaum A, Yee J. Correlation of radiographic measurements and Pulmonary function tests in Chronic Obstructive Pulmonary Disease. AJR Am J Roentgenol 1985; 144:695-699.
10. Greene R. "Saber-Sheath" trachea: Relation to Chronic Obstructive Pulmonary Disease. AJR Am J Roentgenol 1978; 130:441-445.
11. Fiore D, Biondetti PR, Sartori F, Calabro F. The role of computed tomography in the evaluation of bullous lung disease. J Comput Assist Tomogr 1982; 6:105-108.
12. Carr DH, Pride NB. Computed tomography in pre-operative assessment of bullous emphysema. Clin Radiol 1984; 35:43-45.
13. Morgan MD, Denison DM, Strickland B. Value of computed tomography for selecting patients with bullous lung disease for surgery. Thorax 1986; 41:855-862.
14. Stern EJ, Webb WR, Weinacker A, Muller NL. Idiopathic giant bullous emphysema (vanishing lung syndrome): imaging findings in nine patients. AJR Am J Roentgenol 1994; 162:279-282.
15. Bergin C, Muller N, Nichols DM, Lillington G, Hogg JC, Mullen B, Grymaloski MR, Osborne S, Pare PD. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986; 133:541-546.
16. Hruban RH, Meziane MA, Zerhouni EA, Khouri NF, Fishman EK, Wheeler PS, Dumler JS, Hutchins GM. High resolution computed tomography of inflation-fixed lungs. pathologicradiologic correlation of centrilobular emphysema. Am Rev Respir Dis 1987; 136:935-940.
17. Kuwano K, Matsuba K, Ikeda T, Murakami J, Araki A, Nishitani H, Ishida T, Yasumoto K, Shigematsu N. The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores. Am Rev Respir Dis 1990; 141:169-178.
18. Miller RR, Muller NL, Vedal S, Morrison NJ, Staples CA. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989; 139:980-983.
19. Spouge D, Mayo JR, Cardoso W, Muller NL. Panacinar emphysema: CT and pathologic findings. J Comput Assist Tomogr 1993; 17:710-713.
20. Gurney JW, Jones KK, Robbins RA, Gossman GL, Nelson KJ, Daughton D, Spurzem JR, Rennard SI. Regional distribution of emphysema: Correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology 1992; 183:457-463.
21. Remy-Jardin M, Remy J, Boulenguez C, Sobaszek A, Edme JL, Furon D. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology 1993; 186:107-115.
22. Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, Sobaszek A. Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002; 222:261-270.
23. Bense L, Lewander R, Eklund G, Hedenstierna G, Wiman LG. Nonsmoking, non-alpha 1-antitrypsin deficiency-induced emphysema in nonsmokers with healed spontaneous pneumothorax, identified by computed tomography of the lungs. Chest 1993; 103:433-438.
24. Lesur O, Delorme N, Fromaget JM, Bernadac P, Polu JM. Computed tomography in the etiologic assessment of idiopathic spontaneous pneumothorax. Chest 1990; 98:341-347.
25. Shaker SB, Stavngaard T, Stolk J, Stoel B, Dirksen A. Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha 1-antitrypsin deficiency. Thorax 2004; 59:986-991.
26. Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 1992; 45:260-266.
27. King MA, Stone JA, Diaz PT, Mueller CF, Becker WJ, Gadek JE. Alpha 1-antitrypsin deficiency: Evaluation of bronchiectasis with CT. Radiology 1996; 199:137-141.
28. Stavngaard T, Shaker SB, Bach KS, Stoel BC, Dirksen A. Quantitative assessment of regional emphysema distribution in patients with chronic obstructive pulmonary disease (COPD). Acta Radiol 2006; 47:914-921.
29. Mayo JR, Aldrich J, Muller NL. Radiation exposure at chest CT: A statement of the fleischner society. Radiology 2003; 228:15-21.
30. Naidich DP, Marshall CH, Gribbin C, Arams RS, McCauley DI. Low-dose CT of the lungs: Preliminary observations. Radiology 1990; 175:729-731.
31. Zwirewich CV, Mayo JR, Muller NL. Low-dose high-resolution CT of lung parenchyma. Radiology 1991; 180:413-417.
32. Shaker SB, Dirksen A, Laursen LC, Maltbaek N, Christensen L, Sander U, Seersholm N, Skovgaard LT, Nielsen L, Kok-Jensen A. Short-term reproducibility of computed tomography based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema. Acta Radiol 2004; 45:424-430.
33. Muller NL, Staples CA, Miller RR, Abboud RT. "Density Mask". An objective method to quantitate emphysema using computed tomography. Chest 1988; 94:782-787.
34. Gevenois PA, De M, V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152:653-657.
35. Gevenois PA, De Vuyst P, De M, V, Zanen J, Jacobovitz D, Cosio MG, Yernault JC. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154:187-192.
36. Kemerink GJ, Kruize HH, Lamers RJ, van Engelshoven JM. CT lung densitometry: dependence of ct number histograms on sample volume and consequences for scan protocol comparability. J Comput Assist Tomogr 1997; 21:948-954.
37. Shaker SB Methodological Aspects of Quantitative Computed Tomography in Pulmonary Emphysema.: PhD Thesis, University of Copenhagen; 2005.
38. Gould GA, MacNee W, McLean A, Warren PM, Redpath A, Best JJ, Lamb D, Flenley DC. CT measurements of lung density in life can quantitate distal airspace enlargement - an essential defining feature of human emphysema. Am Rev Respir Dis 1988; 137:380-392.
39. Dirksen A, Friis M, Olesen KP, Skovgaard LT, Sorensen K. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Acta Radiol 1997; 38:826-832.
40. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DC, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160:1468-1472.
41. Dowson LJ, Guest PJ, Hill SL, Holder RL, Stockley RA. High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: Relationship to lung function and health status. Eur Respir J 2001; 17:1097-1104.
42. Gould GA, Redpath AT, Ryan M, Warren PM, Best JJ, Flenley DC, MacNee W. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991; 4:141-146.
43. Kinsella M, Muller NL, Abboud RT, Morrison NJ, DyBuncio A. Quantitation of emphysema by computed tomography using a "Density Mask" program and correlation with pulmonary function tests. Chest 1990; 97:315-321.
44. Klein JS, Gamsu G, Webb WR, Golden JA, Muller NL. High-resolution CT Diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 1992; 182:817-821.
45. Schwaiblmair M, Beinert T, Seemann M, Behr J, Reiser M, Vogelmeier C. Relations between cardiopulmonary exercise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency. Eur J Med Res 1998; 3:527-532.
46. Dawkins PA, Dowson LJ, Guest PJ, Stockley RA. Predictors of mortality in alpha1-antitrypsin deficiency. Thorax 2003; 58:1020-1026.
47. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334.
48. Shaker SB, Maltbaek N, Brand P, Haeussermann S, Dirksen A. Quantitative computed tomography and aerosol morphometry in COPD and alpha1-antitrypsin deficiency. Eur Respir J 2005; 25:23-30.
49. Stoel BC, Vrooman HA, Stolk J, Reiber JH. Sources of error in lung densitometry with CT. Invest Radiol 1999; 34:303-309.
50. Becker MD, Berkmen YM, Austin JH, Mun IK, Romney BM, Rozenshtein A, Jellen PA, Yip CK, Thomashow B, Ginsburg ME. Lung volumes before and after lung volume reduction surgery: Quantitative CT analysis. Am J Respir Crit Care Med 1998; 157:1593-1599.
51. Stoel BC, Stolk J. Optimization and standardization of lung densitometry in the assessment of pulmonary emphysema. Invest Radiol 2004; 39:681-688.
52. Parr DG, Stoel BC, Stolk J, Nightingale PG, Stockley RA. Influence of calibration on densitometric studies of emphysema progression using computed tomography. Am J Respir Crit Care Med 2004; 170:883-890.
53. Newell JD, Jr., Hogg JC, Snider GL. Report of a workshop: Quantitative computed tomography scanning in longitudinal studies of emphysema. Eur Respir J 2004; 23:769-775.
54. Nakano Y, Coxson HO, Bosan S, Rogers RM, Sciurba FC, Keenan RJ, Walley KR, Pare PD, Hogg JC. Core to rind distribution of severe emphysema predicts outcome of lung volume reduction surgery. Am J Respir Crit Care Med 2001; 164:2195-2199.
55. Uppaluri R, Hoffman EA, Sonka M, Hartley PG, Hunninghake GW, McLennan G. Computer recognition of regional lung disease patterns. Am J Respir Crit Care Med 1999; 160:648-654.
56. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
57. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166:329-332.
58. Vestbo J, Hogg JC. Convergence of the epidemiology and pathology of COPD. Thorax 2006; 61:86-88.
59. Turato G, Zuin R, Saetta M. Pathogenesis and pathology of COPD. Respiration 2001; 68:117-128.
60. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in Chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653.
61. Fraser RG, Fraser RS, Renner JW, Bernard C, Fitzgerald PJ. The roentgenologic diagnosis of chronic bronchitis: A reassessment with emphasis on parahilar bronchi seen end-on. Radiology 1976; 120:1-9.
62. Guckel C, Hansell DM. Imaging the 'Dirty Lung' - has high resolution computed tomography cleared the smoke? Clin Radiol 1998; 53:717-722.
63. Matthay RA, Schwarz MI, Ellis JH, Jr., Steele PP, Siebert PE, Durrance JR, Levin DC. Pulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiography. Invest Radiol 1981; 16:95-100.
64. Coxson HO, Rogers RM. Quantitative computed tomography of chronic obstructive pulmonary disease. Acad Radiol 2005; 12:1457-1463.
65. de Jong PA, Muller NL, Pare PD, Coxson HO. Computed tomographic imaging of the airways: Relationship to structure and function. Eur Respir J 2005; 26:140-152.
66. Okazawa M, Muller N, McNamara AE, Child S, Verburgt L, Pare PD. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med 1996; 154:1557-1562.
67. Seneterre E, Paganin F, Bruel JM, Michel FB, Bousquet J. Measurement of the internal size of bronchi using high resolution computed tomography (HRCT). Eur Respir J 1994; 7:596-600.
68. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Pare PD, Hogg JC, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162:1102-1108.
69. Orlandi I, Moroni C, Camiciottoli G, Bartolucci M, Pistolesi M, Villari N, Mascalchi M. Chronic Obstructive Pulmonary Disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005; 234:604-610.
70. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, Coxson HO, Elliott WM, Hogg JC, Pare PD. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005; 171:142-146.
71. Hasegawa M, Nasuhara Y, Onodera Y, Makita H, Nagai K, Fuke S, Ito Y, Betsuyaku T, Nishimura M. Airflow limitation and airway dimensions in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2006; 173:1309-1315.
72. Satoh K, Nakano S, Tanabe M, Nishiyama Y, Takahashi K, Kobayashi T, Honjo N, Sasaki M, Fujita J, Okada H. A clinical comparison between technegas SPECT, CT, and pulmonary function tests in patients with emphysema. Radiat Med 1997; 15:277-282.
73. Higuchi T, Reed A, Oto T, Holsworth L, Ellis S, Bailey MJ, Williams TJ, Snell GI. Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax 2006; 61:409-413.
74. Suga K, Kume N, Matsunaga N, Ogasawara N, Motoyama K, Hara A, Matsumoto T. Relative preservation of peripheral lung function in smoking-related pulmonary emphysema: Assessment with 99mTc-MAA perfusion and dynamic 133Xe SPET. Eur J Nucl Med 2000; 27:800-806.
75. Cunningham DA, Lavender JP. Krypton 81m ventilation scanning in chronic obstructive airways disease. Br J Radiol 1981; 54:110-116.
76. Reinartz P, Wildberger JE, Schaefer W, Nowak B, Mahnken AH, Buell U. Tomographic imaging in the diagnosis of pulmonary embolism: A comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med 2004; 45:1501-1508.
77. Stavngaard T, Mortensen J. Assessment of ventilation inhomogenity with krypton SPECT and planar imaging. Clin Physiol Funct Imaging 2005; 25:106-112.
78. Hartmann IJ, Hagen PJ, Melissant CF, Postmus PE, Prins MH. Diagnosing acute pulmonary embolism: effect of Chronic Obstructive Pulmonary Disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in new technologies evaluating the localization of pulmonary embolism. Am J Respir Crit Care Med 2000; 162:2232-2237.
79. Lesser BA, Leeper KV, Jr., Stein PD, Saltzman HA, Chen J, Thompson BT, Hales CA, Popovich J, Jr., Greenspan RH, Weg JG. The Diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest 1992; 102:17-22.
80. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073.
81. Cederlund K, Tylen U, Jorfeldt L, Aspelin P. Classification of emphysema in candidates for lung volume reduction surgery: A new objective and surgically oriented model for describing CT severity and heterogeneity. Chest 2002; 122:590-596.
82. Stavngaard T, Shaker SB, Dirksen A. Quantitative Assessment of Emphysema Distribution in Smokers and Patients With Alpha1-Antitrypsin Deficiency. Respir Med 2006; 100:94-100.
83. McKenna RJ, Jr., Brenner M, Fischel RJ, Singh N, Yoong B, Gelb AF, Osann KE. Patient selection criteria for lung volume reduction surgery. J Thorac Cardiovasc Surg 1997; 114:957-964.
84. Thurnheer R, Engel H, Weder W, Stammberger U, Laube I, Russi EW, Bloch KE. Role of lung perfusion scintigraphy in relation to chest computed tomography and pulmonary function in the evaluation of candidates for lung volume reduction surgery. Am J Respir Crit Care Med 1999; 159:301-310.
85. Cleverley JR, Desai SR, Wells AU, Koyama H, Eastick S, Schmidt MA, Charrier CL, Gatehouse PD, Goldstraw P, Pepper JR, et al. Evaluation of patients undergoing lung volume reduction surgery: ancillary information available from computed tomography. Clin Radiol 2000; 55:45-50.
86. Salzman SH. Can CT measurement of emphysema severity aid patient selection for lung volume reduction surgery? Chest 2000; 118:1231-1232.
87. Sandek K, Bratel T, Lagerstrand L, Rosell H. Relationship between lung function, ventilation-perfusion inequality and extent of emphysema as assessed by high-resolution computed tomography. Respir Med 2002; 96:934-943.
88. Cederlund K, Hogberg S, Jorfeldt L, Larsen F, Norman M, Rasmussen E, Tylen U. Lung perfusion scintigraphy prior to lung volume reduction surgery. Acta Radiol 2003; 44:246-251.
89. Bolliger CT, Guckel C, Engel H, Stohr S, Wyser CP, Schoetzau A, Habicht J, Soler M, Tamm M, Perruchoud AP. Prediction of functional reserves after lung resection: comparison between quantitative computed tomography, scintigraphy, and anatomy. Respiration 2002; 69:482-489.
90. Sudoh M, Ueda K, Kaneda Y, Mitsutaka J, Li TS, Suga K, Kawakami Y, Hamano K. Breath-hold single-photon emission tomography and computed tomography for predicting residual pulmonary function in patients with lung cancer. J Thorac Cardiovasc Surg 2006; 131:994-1001.
91. Yeates DB, Mortensen J Deposition and Clearance. In: Murray JF NJ, editor. Textbook of Respiratory Medicine, 3rd ed. Philadelphia: WB Saunders Company; 2000. pp. 349-384.
92. Stavngaard T, Mortensen J, Dirksen A. Emphysema/Alpha-1 antitrypsin deficiency. In: Lipson DA, van Beek EJR, editors. Functional Lung Imaging, 1st ed. Boca Raton: CRC Press, Taylor and Francis group; 2005. pp. 453-478.
93. Altes TA, Rehm PK, Harrell F, Salerno M, Daniel TM, de Lange EE. Ventilation imaging of the lung: comparison of hyperpolarized Helium-3 MR imaging with Xe-133 scintigraphy. Acad Radiol 2004; 11:729-734.
94. Stavngaard T, Sogaard LV, Mortensen J, Hanson LG, Schmiedeskamp J, Berthelsen AK, Dirksen A. Hyperpolarized 3He MRI and 81mKr SPECT in Chronic Obstructive Pulmonary Disease. Eur J Nucl Med Mol Imaging 2005; 32:448-457.
95. Johkoh T, Muller NL, Kavanagh PV, Cartier Y, Mayo JR, Tomiyama N, Murakami T, Naito H, Nakamura H, Moriya H. Scintigraphic and MR perfusion imaging in preoperative evaluation for lung volume reduction surgery: pilot study results. Radiat Med 2000; 18:277-281.
96. Bergin CJ, Glover GM, Pauly J. Magnetic resonance imaging of lung parenchyma. J Thorac Imaging 1993; 8:12-17.
97. Kauczor HU, Hofmann D, Kreitner KF, Nilgens H, Surkau R, Heil W, Potthast A, Knopp MV, Otten EW, Thelen M. Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. Radiology 1996; 201:564-568.
98. Gierada DS, Saam B, Yablonskiy D, Cooper JD, Lefrak SS, Conradi MS. Dynamic Echo Planar MR Imaging of Lung Ventilation With Hyperpolarized (3)He in Normal Subjects and Patients With Severe Emphysema. NMR Biomed 2000; 13:176-181.
99. Salerno M, Altes TA, Mugler JP, III, Nakatsu M, Hatabu H, de Lange EE. Hyperpolarized Noble gas MR imaging of the lung: potential clinical applications. Eur J Radiol 2001; 40:33-44.
100. Saam BT, Yablonskiy DA, Kodibagkar VD, Leawoods JC, Gierada DS, Cooper JD, Lefrak SS, Conradi MS. MR Imaging of diffusion of (3)he gas in healthy and diseased lungs. Magn Reson Med 2000; 44:174-179.
101. Salerno M, de Lange EE, Altes TA, Truwit JD, Brookeman JR, Mugler JP, III. Emphysema: hyperpolarized Helium 3 diffusion MR imaging of the lungs compared with spirometric indexes-Initial Experience. Radiology 2002; 222:252-260.
102. 2(2) concentration by MR imaging of inhaled hyperpolarized helium-3. J Appl Physiol 1999; 87:2043-2052.
103. Deninger AJ, Eberle B, Bermuth J, Escat B, Markstaller K, Schmiedeskamp J, Schreiber WG, Surkau R, Otten E, Kauczor HU. Assessment of a single-acquisition imaging sequence for oxygen-sensitive (3)He-MRI. Magn Reson Med 2002; 47:105-114.
104. Ohno Y, Hatabu H, Takenaka D, Adachi S, Van Cauteren M, Sugimura K. Oxygen-enhanced MR ventilation imaging of the lung: preliminary clinical experience in 25 subjects. AJR Am J Roentgenol 2001; 177:185-194.